About Broncus
Broncus is a company based in San Jose (United States) founded in 1997.. Broncus has raised $44.5 million across 4 funding rounds from investors including Intuitive, Qiming Venture Partners and Abingworth. The company has 200 employees as of December 31, 2024. Broncus has completed 1 acquisition, including Uptake Medical. Broncus operates in a competitive market with competitors including Oncimmune, Biodesix, OncoCyte, Riverain Tech and ONCOHOST, among others.
- Headquarter San Jose, United States
- Employees 200 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Broncus Holding Corp.
-
Annual Revenue
$8.17 M (USD)-20.97as on Dec 31, 2024
-
Net Profit
$-15.38 M (USD)45.7as on Dec 31, 2024
-
EBITDA
$-19.37 M (USD)36.71as on Dec 31, 2024
-
Total Equity Funding
$44.5 M (USD)
in 4 rounds
-
Latest Funding Round
-
Investors
Intuitive
& 19 more
-
Employee Count
200
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Broncus
Broncus is a publicly listed company on the HKEX with ticker symbol 2216 in Hong Kong, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Broncus
Broncus has successfully raised a total of $44.5M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Last Round
-
First Round
First Round
(30 Aug 2006)
- Investors Count 20
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2021 | Amount | Series D - Broncus | Valuation | FountainVest Partners | |
| Oct, 2020 | Amount | Series C - Broncus | Valuation | Lake Bleu Capital | |
| Jun, 2018 | Amount | Series A - Broncus | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Broncus
Broncus has secured backing from 20 investors, including venture fund and institutional investors. Prominent investors backing the company include Intuitive, Qiming Venture Partners and Abingworth. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
FountainVest is involved in investment or financial services.
|
Founded Year | Domain | Location | |
|
Exome Asset Management is focused on healthcare industry investments.
|
Founded Year | Domain | Location | |
|
Summer Capital is engaged in multi-strategy investment advisory services.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Broncus
Broncus has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Uptake Medical. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Targeted vapor therapy is developed for endoscopic lung volume reduction.
|
2005 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Broncus
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Broncus Comparisons
Competitors of Broncus
Broncus operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Oncimmune, Biodesix, OncoCyte, Riverain Tech and ONCOHOST, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Diagnostics and risk assessment solutions for lung cancer are developed.
|
|
| domain | founded_year | HQ Location |
Cancer detection diagnostics assays are developed and offered.
|
|
| domain | founded_year | HQ Location |
Non-invasive diagnostic test solutions for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Software tools are developed for early lung disease detection.
|
|
| domain | founded_year | HQ Location |
AI-based proteomic analysis for oncology therapy planning is offered.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Broncus
Frequently Asked Questions about Broncus
When was Broncus founded?
Broncus was founded in 1997 and raised its 1st funding round 9 years after it was founded.
Where is Broncus located?
Broncus is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
Is Broncus a funded company?
Broncus is a funded company, having raised a total of $44.5M across 4 funding rounds to date. The company's 1st funding round was a Series A of $15M, raised on Aug 30, 2006.
How many employees does Broncus have?
As of Dec 31, 2024, the latest employee count at Broncus is 200.
What is the annual revenue of Broncus?
Annual revenue of Broncus is $8.17M as on Dec 31, 2024.
What does Broncus do?
Broncus was founded in 1997 and is headquartered in San Jose, United States. Operations focus on the medical device sector, with minimally invasive navigation, diagnostic, and therapeutic solutions provided for lung diseases. An intellectual property portfolio comprising 75 patents, including issued, licensed, and pending ones, is maintained. The LungPoint Virtual Bronchoscopic Navigation System is utilized for image-guided planning and navigation to lung tumors in a commercial-stage context.
Who are the top competitors of Broncus?
Is Broncus publicly traded?
Yes, Broncus is publicly traded on HKEX under the ticker symbol 2216.
How many acquisitions has Broncus made?
Broncus has made 1 acquisition, including Uptake Medical.
Who are Broncus's investors?
Broncus has 20 investors. Key investors include Intuitive, Qiming Venture Partners, Abingworth, HBM Healthcare Investments, and Japan Asia Investment.
What is Broncus's ticker symbol?
The ticker symbol of Broncus is 2216 on HKEX.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.